Skip to main content
Premium Trial:

Request an Annual Quote

Myriad Genetics, Biosearch Italia Enter Novel Microbe-Based Drug-Discovery Pact

NEW YORK, Nov. 27 - Myriad Genetics and Biosearch Italia have formed a collaboration to discover novel microbial-based therapeutic compounds, the companies said on Tuesday.

 

Under the terms of the alliance, Biosearch will provide Myriad with access to its library of micro-organisms and microbial extracts, from which Myriad will select promising drug targets and develop high-throughput screening assays.

 

Although financial terms of the deal were not disclosed, the firms said they agreed to share development rights to any resulting compounds. They added that the partnership will not be limited to micro-organism research.

 

"This collaboration will enable Biosearch to recognize value from our natural product library outside our core focus of anti-infectives discovery and development," said Francesco Parenti, president and chief scientific officer of Biosearch Italia.

 

Adrian Hobden, president of Myriad Pharmaceuticals, added: "There is exciting potential through this collaboration.…" Used together, the companies' technologies "may lead to the development of new therapeutics."

 

According to Biosearch, the collaboration "will complement … the extensive drug discovery research conducted directly by Biosearch, making use of its mechanism-based assays."

 

The company, based in Gerenzano, Italy, is known for its rich library of micro-organisms and microbial extracts that it isolates and cultivates in order to obtain a wide range of molecules.

 

Myriad's drug-development approach, meanwhile, relies on its proteomics platform, ProNet, to identify novel drug targets and their disease pathways. The Salt Lake City-based company then screens these targets to identify new lead compounds which it either develops internally or licenses to pharmaceutical companies.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.